RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Shineway Pharmaceutical Group Stock

China Shineway Pharmaceutical Group Liabilities 2024

China Shineway Pharmaceutical Group Liabilities

2.54 B CNY

Ticker

2877.HK

ISIN

KYG2110P1000

WKN

A0DNLW

In 2024, China Shineway Pharmaceutical Group's total liabilities amounted to 2.54 B CNY, a 37.3% difference from the 1.85 B CNY total liabilities in the previous year.

China Shineway Pharmaceutical Group Aktienanalyse

What does China Shineway Pharmaceutical Group do?

China Shineway Pharmaceutical Group Ltd was founded in 1996 and has since become one of the leading Chinese pharmaceutical companies. Based in Beijing, the company offers a wide range of products in various segments, including traditional Chinese medicine, Western medicine, and health products. China Shineway's business model is based on research and development, production, distribution, and marketing of pharmaceutical products. The company strives to advance the development of new drugs and treatment methods by continuously improving its research and development department. The company covers various areas of healthcare, including the manufacturing of remedies for cancer, cardiovascular diseases, orthopedic surgery, and neurology. China Shineway also specializes in the development of herbal medicines for use in traditional Chinese medicine. The company has thus occupied a niche market and is an important provider of natural remedies for various health needs in this niche. Another important aspect of Shineway's business is the production of raw materials for use in other pharmaceutical products. The company has a strong presence in the Chinese market and supplies other companies with pharmaceutical raw materials for drug manufacturing. The company continuously improves its production capacity and implements new technologies for the production of high-quality goods. One of the most well-known products in traditional Chinese medicine at Shineway is Naoxintong. Naoxintong is an herbal medicine used for the treatment of cardiovascular diseases and helps to lower cholesterol levels and blood pressure. The combination of natural plant extracts is unique and has found great demand in China. Another product segment of China Shineway is the business of health products. The company offers high-quality dietary supplements, vitamins, and minerals to improve overall well-being and physical health. The company is committed to ensuring the highest level of quality and safety in all its products. The company also operates a strong international business by exporting its products worldwide. China Shineway has branches in several countries, including Europe, Africa, and Asia, creating access to global markets. Due to the high demand for natural remedies in traditional Chinese medicine, the company has made significant progress in international markets in recent years. China Shineway also has a strong social responsibility and supports numerous charitable and nonprofit organizations in China. The company has launched a donation initiative and distributed medicines and health products for free to those who could not afford them. It is also committed to protecting the environment and invests in environmentally friendly technologies to reduce its carbon footprint. Overall, China Shineway has established itself as an important company in the Chinese pharmaceutical industry and has managed to be successful both internationally and in the domestic market. The company is committed to continuing its commitment to research and development to provide even better drugs and treatment methods in the future. China Shineway Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing China Shineway Pharmaceutical Group's Liabilities

China Shineway Pharmaceutical Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating China Shineway Pharmaceutical Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing China Shineway Pharmaceutical Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

China Shineway Pharmaceutical Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in China Shineway Pharmaceutical Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about China Shineway Pharmaceutical Group stock

What is the level of liabilities of China Shineway Pharmaceutical Group this year?

China Shineway Pharmaceutical Group has a debt balance of 2.54 B CNY this year.

What were the liabilities of China Shineway Pharmaceutical Group compared to the previous year?

The liabilities of China Shineway Pharmaceutical Group have increased by 37.3% increased compared to the previous year.

What are the consequences of high debt for investors of China Shineway Pharmaceutical Group?

High liabilities can pose a risk for investors of China Shineway Pharmaceutical Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in China Shineway Pharmaceutical Group?

Low liabilities mean that China Shineway Pharmaceutical Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of China Shineway Pharmaceutical Group affect the company?

An increase in liabilities of China Shineway Pharmaceutical Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of China Shineway Pharmaceutical Group affect the company?

A decrease in the liabilities of China Shineway Pharmaceutical Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of China Shineway Pharmaceutical Group?

Some factors that can influence the liabilities of China Shineway Pharmaceutical Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of China Shineway Pharmaceutical Group so important for investors?

The liabilities of China Shineway Pharmaceutical Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can China Shineway Pharmaceutical Group take to modify the liabilities?

To change its liabilities, China Shineway Pharmaceutical Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does China Shineway Pharmaceutical Group pay?

Over the past 12 months, China Shineway Pharmaceutical Group paid a dividend of 0.47 CNY . This corresponds to a dividend yield of about 5.57 %. For the coming 12 months, China Shineway Pharmaceutical Group is expected to pay a dividend of 0.49 CNY.

What is the dividend yield of China Shineway Pharmaceutical Group?

The current dividend yield of China Shineway Pharmaceutical Group is 5.57 %.

When does China Shineway Pharmaceutical Group pay dividends?

China Shineway Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, May, June, October.

How secure is the dividend of China Shineway Pharmaceutical Group?

China Shineway Pharmaceutical Group paid dividends every year for the past 22 years.

What is the dividend of China Shineway Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.49 CNY are expected. This corresponds to a dividend yield of 5.84 %.

In which sector is China Shineway Pharmaceutical Group located?

China Shineway Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Shineway Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Shineway Pharmaceutical Group from 9/27/2024 amounting to 0.12 CNY, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did China Shineway Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of China Shineway Pharmaceutical Group in the year 2023?

In the year 2023, China Shineway Pharmaceutical Group distributed 0.383 CNY as dividends.

In which currency does China Shineway Pharmaceutical Group pay out the dividend?

The dividends of China Shineway Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Shineway Pharmaceutical Group

Our stock analysis for China Shineway Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Shineway Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.